SEC Filing Details

SEC Filing Details

Document Details

Form
S-8 POS
Filing Date
Sep 24, 2026
Document Date
Sep 24, 2026
Form Description
Post-effective amendment to an S-8 filing
Filing Group
Registration Statements
Company
Theravance Biopharma
Issuer
Theravance Biopharma, Inc.

©2019- Theravance Biopharma.  All rights reserved.  Terms of Use.  Global Privacy Notice.  Social Media Guidelines. US Supplemental Privacy Notice.

THERAVANCE BIOPHARMA®, THERAVANCE®, the Cross/Star logo and MEDICINES THAT MAKE A DIFFERENCE®, are registered trademarks, and TARGETING WHAT MATTERS MOST™ is a trademark of the Theravance Biopharma group of companies (in the U.S. and certain other countries). YUPELRI® is a registered trademark of Mylan Specialty L.P., a Viatris Company. Trademarks, trade names or service marks of other companies appearing on this website are the property of their respective owners.